- Home
- PM vs ABBV Comparison
PM vs ABBV Comparison
Compare PM & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PM
- ABBV
- Stock Information
- Founded
- PM 1987
- ABBV 2012
- Country
- PM United States
- ABBV United States
- Employees
- PM N/A
- ABBV N/A
- Industry
- PM Medicinal Chemicals and Botanical Products
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- PM Health Care
- ABBV Health Care
- Exchange
- PM Nasdaq
- ABBV Nasdaq
- Market Cap
- PM 283.9B
- ABBV 338.3B
- IPO Year
- PM N/A
- ABBV N/A
- Fundamental
- Price
- PM $179.78
- ABBV $192.34
- Analyst Decision
- PM Strong Buy
- ABBV Buy
- Analyst Count
- PM 13
- ABBV 22
- Target Price
- PM $174.31
- ABBV $213.14
- AVG Volume (30 Days)
- PM 5.2M
- ABBV 7.0M
- Earning Date
- PM 07-22-2025
- ABBV 07-31-2025
- Dividend Yield
- PM 3.00%
- ABBV 3.41%
- EPS Growth
- PM N/A
- ABBV N/A
- EPS
- PM 4.86
- ABBV 2.34
- Revenue
- PM $38,386,000,000.00
- ABBV $57,367,000,000.00
- Revenue This Year
- PM $11.78
- ABBV $8.48
- Revenue Next Year
- PM $8.32
- ABBV $8.19
- P/E Ratio
- PM $36.99
- ABBV $82.25
- Revenue Growth
- PM 6.78
- ABBV 5.45
- 52 Week Low
- PM $102.75
- ABBV $163.81
- 52 Week High
- PM $186.69
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- PM 50.75
- ABBV 57.06
- Support Level
- PM $176.30
- ABBV $186.67
- Resistance Level
- PM $181.14
- ABBV $197.50
- Average True Range (ATR)
- PM 3.29
- ABBV 4.31
- MACD
- PM -0.55
- ABBV 0.70
- Stochastic Oscillator
- PM 44.97
- ABBV 67.28
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).